Drugs / Autologous CD34+ Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03471611 | Jun 2018 → Oct 2020 | coronary atherosclerosis | Mayo Clinic | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous CD34+ Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03471611 ↗ |
| Modality | Cell therapy | “We evaluated safety and potential efficacy of intracoronary autologous CD34+ cell therapy for CED.” PMID 34923853 ↗ Dec 2021 |